Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Loss of 10q26.1-q26.3 in association with 7q34-q36.3 gain or 17q24.3-q25.3 gain predict poor outcome in pediatric medulloblastoma.
Pezzolo A, Coco S, Raso A, Parodi F, Pistorio A, Valdora F, Capra V, Zollo M, Aschero S, Basso E, Cama A, Nozza P, Gambini C, Cinalli G, Garrè ML, Iolascon A, Pistoia V, Tonini GP. Pezzolo A, et al. Among authors: parodi f. Cancer Lett. 2011 Sep 28;308(2):215-24. doi: 10.1016/j.canlet.2011.05.006. Epub 2011 Jun 8. Cancer Lett. 2011. PMID: 21652146
Tumor origin of endothelial cells in human neuroblastoma.
Pezzolo A, Parodi F, Corrias MV, Cinti R, Gambini C, Pistoia V. Pezzolo A, et al. Among authors: parodi f. J Clin Oncol. 2007 Feb 1;25(4):376-83. doi: 10.1200/JCO.2006.09.0696. J Clin Oncol. 2007. PMID: 17264333
A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy.
Sidarovich V, De Mariano M, Aveic S, Pancher M, Adami V, Gatto P, Pizzini S, Pasini L, Croce M, Parodi F, Cimmino F, Avitabile M, Emionite L, Cilli M, Ferrini S, Pagano A, Capasso M, Quattrone A, Tonini GP, Longo L. Sidarovich V, et al. Among authors: parodi f. Mol Cancer Ther. 2018 Jul;17(7):1405-1415. doi: 10.1158/1535-7163.MCT-17-0841. Epub 2018 Apr 25. Mol Cancer Ther. 2018. PMID: 29695637
378 results